Abstract:Objective:To evaluate the diagnostic for classification of newly diagnosed diabetes patients and assess the application of the screening tests recommended by the 2022 Chinese Expert Consensus on Diabetes Classification.Methods:Retrospective case series study. The data from the electronic medical record system of patients with new-onset diabetes mellitus (within 1 year of disease onset) who attending the Diabetes Specialist Outpatient Clinic at the Second Xiangya Hospital of Central South University from January 1, 2018 to December 31, 2021 were collected for the analysis. Based on the consensus, patients were categorized according their age of onset, body mass index (BMI), and suspicion of type 1 diabetes mellitus (T1DM). The chi-square statistic was used to compare key classifier indicators, including C-peptide, islet autoantibodies, and genetic markers, in the subgroups. The diagnosis in suspected T1DM patients was also evaluated. The screening strategy recommended in the consensus was further assessed using a logistic regression model and the area under the receiver-operating curve (AUC).Results:A total of 3 384 patients with new-onset diabetes were included. The average age of disease onset was (46.3±13.9) years, and 61.0% (2 065/3 384) of the patients were male. The proportions of patients who completed C-peptide and glutamic acid decarboxylase antibody (GADA) tests were 36.6% (1 238/3 384) and 37.5% (1 269/3 384), respectively. There were no significant differences in C-peptide test results among the subgroups (all P>0.05). In contrast, the GADA detection rate was higher in patients with young age of onset (<30 years old), in those who were non-obese (BMI<24 kg/m 2), and in those clinically suspected of T1DM (all P<0.05). According to the diagnostic pathway proposed by the consensus, only 57.4% (1 941/3 384) of patients could be subtyped. For a definitive diagnosis, the remaining patients needed completion of C-peptide, islet autoantibody, genetic testing, or follow-up. Furthermore, among patients with clinical features of suspected T1DM, the antibody positivity rate was higher than in non-suspected T1DM patients [24.5% (154/628) vs. 7.1% (46/646), P<0.001]. When the clinical features of suspected T1DM defined in the consensus were taken as independent variables and antibody positivity was considered the outcome variable in the logistic regression model, young onset, non-obese onset, and ketosis onset could enter the model. Based on AUC analysis, the accuracy of the diagnostic model was 0.77 (95% CI 0.73-0.81), suggesting that the clinical features of suspected T1DM in the consensus have good clinical diagnostic value for this patient subgroup. Conclusions:There was a significant discrepancy between the clinical practice of diabetes classification and the process recommended by the consensus, which was specifically reflected in the low proportions of both subtyping indicator testing and definitively subtyped diabetes patients. Attention should be pay to the classification diagnosis process proposed in the consensus and the clinical detection rate of key diabetes subtyping indicators such as C-peptide and islet autoantibodies for diabetes classification should be improved. Noteworthy, the screening strategy for T1DM proposed by the consensus showed good clinical application value.

Clinical characteristics and classification of 2 128 outpatients with diabetes

[Clinical Characteristics and Classification of 2128 Outpatients with Diabetes].

Analysis of the clinical characteristics and differential diagnosis in 186 cases with type 1 and type 2 diabetes in young adult and children

Clinical Characteristics of 109 Children with Newly Diagnosed as Type 1 Diabetes Mellitus

Clinical Incidence and Characteristics of Newly Diagnosed Type 1 Diabetes in Chinese Children and Adolescents: A Nationwide Registry Study of 34 Medical Centers.

[Clinical Characteristics and Classification Diagnosis of Newly Diagnosed Diabetes Onset with Ketosis or Ketoacidosis in Adult Patients].

Glycemic Control Rate of T2DM Outpatients in China: A Multi-Center Survey

Study on the Positive Frequency and Distribution of Glutamic Acid Decarboxylase Antibody in Phenotypic Type 2 Diabetic Patients

[Study on the Postive Frequency and Distribution of Glutamic Acid Decarboxylase Antibody in Phenotypic Type 2 Diabetec Patients].

Clinical characteristics of patients with early-onset diabetes mellitus: a single-center retrospective study

[Clinical characteristics of early-onset type 2 diabetes and risk factors associated with its chronic complications].

Current state of treatment and management of diabetic patients in the outpatient clinic

Change of Glutamic Acid Decarboxylase Antibody and Protein Tyrosine Phosphatase Antibody in Chinese Patients with Acute-Onset Type 1 Diabetes Mellitus

Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort Study.

Persistence of Glutamic Acid Decarboxylase Antibody (GADA) is Associated with Clinical Characteristics of Latent Autoimmune Diabetes in Adults: a Prospective Study with 3-Year Follow-Up.

Prevalence and Identification of Type 1 Diabetes in Chinese Adults with Newly Diagnosed Diabetes

Demographic and Clinical Characteristics of Patients with Type 1 Diabetes Mellitus: A Multicenter Registry Study in Guangdong, China

The Clinical Characteristics of Double Diabetes

Clinical Characteristics and Classification of Diabetic Patients with Ketosis-Onset

Application of the Chinese Expert Consensus on Diabetes Classification in Clinical Practice

Analysis of 2864 Cases of Pregnant Women in a Single Center Results of Oral 75 G Anhydrous Glucose Tolerance Test